Featured Jobs
|
MAP Retirement
|
|
DWC - The 401(k) Experts
|
|
DWC - The 401(k) Experts
|
|
Retirement Plan Onboarding Specialist Compass
|
|
PPS Pension Services
|
Free Newsletters
“BenefitsLink continues to be the most valuable resource we have at the firm.”
-- An attorney subscriber
|
|
|
|
ASPE Analysis of New Generic Markets Effect of Market Entry on Generic Drug Prices: Medicare Data 2007-2022 (PDF)
Assistant Secretary for Planning and Evaluation [ASPE], U.S. Department of Health and Human Services [HHS]
Jan. 17, 2025 "In 2022, it was estimated that 91% of all prescriptions in the United States were filled as generic drugs.... Generic drug prices are consistently lower than brand-name prices across all market sizes and time periods ... The impact of competition on relative drug prices is stable over time: the price reductions are similar for generic drugs first entering the market in the most recent period 2016-2019 compared to both earlier periods, 2007-11 and 2012-15." MORE >> |
| Please click here to report this link if it is broken (for example, if you see a "404 File Not Found" error message after you click on the linked news item's title). |
| An important word about authorship: BenefitsLink® created this link to the news item, but we are not the news item's author (unless expressly shown above). |